Literature DB >> 14980952

Assessing residual neuromuscular blockade using acceleromyography can be deceptive in postoperative awake patients.

Christophe Baillard1, Sylvie Bourdiau, Philippe Le Toumelin, Farid Ait Kaci, Bruno Riou, Michel Cupa, C Marc Samama.   

Abstract

UNLABELLED: Postoperative awake patients may have significant residual neuromuscular block. In awake patients, the results of accelerometry are affected by extra movements to which the thumb may be subject. In this study, we evaluated the repeatability of train-of-four (TOF) ratio using acceleromyography in 253 patients recovering from anesthesia. Immediately after arrival in the postanesthesia care unit, the ulnar nerve was stimulated with TOF stimulation. The evoked response at the thumb was measured by the TOF-Watch apparatus. The current intensity was 30 mA. Two TOF stimulations were applied and recorded at 30-s intervals. A Bland-Altman test was used. The Kappa (kappa) test for clinical agreement between the two measurements was also calculated according to the presence or absence of a residual neuromuscular blockade, defined as a TOF ratio <0.9. According to the presence of a residual neuromuscular blockade, the paired TOF ratios were discordant in 61 patients (24%; 95% confidence interval, 21%-27%). The kappa test indicated a moderate agreement (k = 0.47). We demonstrated that accelerometry as used in this study is not always accurate. Two isolated acceleromyograph TOF ratios are not an accurate representation of the neuromuscular status of the patient recovering from anesthesia. IMPLICATIONS: Clinicians should be aware that acceleromyography as used in this study does not always provide precise train-of-four ratio measurements. Two isolated acceleromyograph train-of-four ratios are not an accurate representation of the neuromuscular status of the patient recovering from anesthesia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980952     DOI: 10.1213/01.ane.0000100150.84698.8c

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

1.  Retrospective analysis of spontaneous recovery from neuromuscular blockade produced by empirical use of rocuronium.

Authors:  Hiroto Yamamoto; Tokujiro Uchida; Yudai Yamamoto; Yusuke Ito; Koshi Makita
Journal:  J Anesth       Date:  2011-09-21       Impact factor: 2.078

2.  A randomized-controlled trial of sugammadex versus neostigmine: impact on early postoperative strength.

Authors:  Ramon E Abola; Jamie Romeiser; Sabeen Rizwan; Brandon Lung; Ruchir Gupta; Elliott Bennett-Guerrero
Journal:  Can J Anaesth       Date:  2020-05-13       Impact factor: 5.063

3.  The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact.

Authors:  Edoardo De Robertis; Geremia Zito Marinosci; Giovanni Marco Romano; Ornella Piazza; Michele Iannuzzi; Fabrizio Cirillo; Stefania De Simone; Giuseppe Servillo
Journal:  Clinicoecon Outcomes Res       Date:  2016-06-29

4.  Development of an algorithm using clinical tests to avoid post-operative residual neuromuscular block.

Authors:  Christoph Unterbuchner; Manfred Blobner; Friedrich Pühringer; Matthias Janda; Sebastian Bischoff; Berthold Bein; Annette Schmidt; Kurt Ulm; Viktor Pithamitsis; Heidrun Fink
Journal:  BMC Anesthesiol       Date:  2017-08-04       Impact factor: 2.217

5.  Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study.

Authors:  Gonzalo Domenech; Matías A Kampel; María E García Guzzo; Delfina Sánchez Novas; Sergio A Terrasa; Gustavo Garcia Fornari
Journal:  BMC Anesthesiol       Date:  2019-08-07       Impact factor: 2.217

6.  Comparison between the Effects of Rocuronium, Vecuronium, and Cisatracurium Using Train-of-Four and Clinical Tests in Elderly Patients.

Authors:  Ozlem Sagir; Funda Yucesoy Noyan; Ahmet Koroglu; Muslum Cicek; Huseyin Ilksen Toprak
Journal:  Anesth Pain Med       Date:  2013-03-26

7.  Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery - a series of 117 cases.

Authors:  Tomas Vymazal; Martina Krecmerova; Vladimír Bicek; Robert Lischke
Journal:  Ther Clin Risk Manag       Date:  2015-10-15       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.